<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01677520</url>
  </required_header>
  <id_info>
    <org_study_id>12.08.004</org_study_id>
    <nct_id>NCT01677520</nct_id>
  </id_info>
  <brief_title>Investigation of Stem Cells in Human Lipoaspirate</brief_title>
  <official_title>Investigation of Adipose-Derived Stem Cells in Human Lipoaspirate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nevada, Las Vegas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nevada, Las Vegas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall purpose of this study is to enhance identification and isolation of ADSCs and
      adipocytes, to find the optimum culturing conditions to increase growth and volume of grafts,
      and to study the effects of cryopreservation on ADSCs and adipocytes. Fat injections are used
      in aesthetic surgery but tend to disassemble over time. If the investigators can enhance
      growth and volume of fat in culture, the investigators could use fat grafts in reconstruction
      of cancer and traumatic injury defects with the patients own cultured fat cells and grafts.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of Viable ADSCs</measure>
    <time_frame>Day of Surgery</time_frame>
    <description>Percent of viable ADSCs will be measured on fresh samples and samples refrigerated for different times.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of Apoptotic ADSCs</measure>
    <time_frame>Day of Surgery</time_frame>
    <description>Percent of apoptotic ADSCs will be measured on fresh samples and on refrigerated samples at 1, 2, 3, and 4 days refrigerated storage.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percent of Necrotic ADSCs</measure>
    <time_frame>Day of Surgery</time_frame>
    <description>Percent of necrotic ADSCs will be measured on fresh samples and on refrigerated samples at 1, 2, 3, and 4 days of refrigerated storage.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>18-30 yrs, 31-50 yrs, 51-70 yrs</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cells from lipoaspirate maximum of 20 days
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary Care Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adults (18-70 yrs) who have scheduled surgical lipectomy of the hips, abdomen, or
             thighs are prospective subjects for this study.

        Exclusion Criteria:

          -  Pregnant women will be excluded to protect the unborn child.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William A Zamboni, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNSOM</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Z Wang, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>wwang@medicine.nevada.edu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William A Zamboni, M.D.</last_name>
    <phone>702-671-2278</phone>
    <email>wzamboni@medicine.nevada.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shelley J Williams, M.S.</last_name>
    <phone>702-895-1445</phone>
    <email>sjwilliams@medicine.nevada.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Nevada School of Medicine Patient Care Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William A Zamboni, M.D.</last_name>
      <email>wzamboni@medicine.nevada.edu</email>
    </contact>
    <contact_backup>
      <last_name>Karen Zamboni, BSRN</last_name>
      <phone>702-671-5118</phone>
      <email>kzamboni@medicine.nevada.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William A Zamboni, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2012</study_first_submitted>
  <study_first_submitted_qc>August 31, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2012</study_first_posted>
  <last_update_submitted>January 8, 2015</last_update_submitted>
  <last_update_submitted_qc>January 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nevada, Las Vegas</investigator_affiliation>
    <investigator_full_name>William A. Zamboni, M.D.</investigator_full_name>
    <investigator_title>Professor and Chair Department of Surgery UNSOM</investigator_title>
  </responsible_party>
  <keyword>adipose-derived stem cells</keyword>
  <keyword>viable ADSCs</keyword>
  <keyword>apoptosis</keyword>
  <keyword>necrosis</keyword>
  <keyword>cryopreservation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

